How often do you monitor AML patients after transplant for recurrence?  

Assuming that your patient was transplanted in CR and there is no plan for maintenance treatment, we typically repeat BM A/Bx at D100, 6 and 12 months after alloSCT. We continue to follow PB myeloid R/D chimerism studies regularly after (q 2-3 months for the next 2 years), obviously with CBC. We do ...